This conference will benefit venture capitalists and angel investors who are interested in early-stage life sciences companies. Key attendees will be business development and senior executives from biotech, pharmaceutical and biomedical companies.
Be among the first to see a range of new companies spun off from Massachusetts research institutions, and see new technologies that are available for commercialization through licensing agreements and the creation of new companies.
MTTC will be glad to consider you as a presenter. To see detailed eligibility criteria and to apply please download the LS 2012 Presenter Application.
MTTC will be glad to consider you as an exhibitor. To see detailed eligibility criteria and to apply please download the LS 2012 ExhibitorApplication
April 12, 2012, 1:00-7:00 pm
Merck Research Laboratories
33 Avenue Louis Pasteur
Boston, MA 02115
The Early-Stage Life Sciences Technology Conference VIII will showcase 20 life sciences technologies developed at the universities, research institutions, and hospitals of Massachusetts and recently formed Massachusetts companies to an audience of angel investors, venture capitalists and corporate investors.
The Forum is an opportunity for these companies and researchers to present to an audience of angel investors, venture capitalists and corporate investors. Companies that have presented at our first seven Early Stage Life Sciences Conferences have raised over $100 million in new investments.
12:45 PM - 1:15 PM Registration and Dessert Bar
1:15 PM - 1:45 PM Welcome and Finance Panel "Rapid Funding Update"
1:45 PM - 3:00 PM Company presentations - Session One
3:00 PM - 3:30 PM Coffee Break
3:30 PM - 5:00 PM Company presentations - Session Two
5:00 PM - 7:00 PM Networking Reception and Poster Session
Moderator: Abigail Barrow Founding Director, Massachusetts Technology Transfer Center and Conference Chair
The Early-Stage Life Sciences Technology Conference is an annual showcase for platform technologies developed at the research institutions, hospitals and universities of Massachusetts and for recently formed Massachusetts companies. Presenters will include founders of new Massachusetts companies and faculty of Massachusetts institutions with technologies that could be the basis of a start-up or license. The Forum is an opportunity for these companies and faculty to present to an audience of angel investors, venture capitalists and corporate investors.
This year Presenters and Exhibitors include:
Advirna, Atentiv, Binotech Laboratories, BioDais, ColdSteel Laser, CytoCure LLC, Excellims, Frontiera Therapeutics, HepatoChem, Lumos Catheter Systems, Massachusetts General Hospital, Nanocanary Technologies, NUChip, Photoral, Segterra, SIband, SignaBlok, Spordiff Therapeutics, Synthegenix Pharmaseuticals, Targeted Cell Therapies, TransCytos, UMass Medical School, Viridis Bio, Visus Technology, VitaThreads, and ZS Genetics.
On-line registration is closed.
On-site Registration will open at 12:45pm on April 12, 2012
at the Ground Floor Lobby at the Merck Research Laboratories, 33 Avenue Louis Pasteur, Boston, MA 02115.
We are looking forward to seeing you there!
$3,000 Sponsorships Available
For sponsorship information, please contact:Abigail Barrow